Literature DB >> 2553656

Susceptibility of anaerobic bacteria to meropenem.

C E Nord1, A Lindmark, I Persson.   

Abstract

The activity of meropenem was determined against 350 strains of anaerobic bacteria by an agar dilution method. It was compared with those of piperacillin, cefoxitin, imipenem, clindamycin, metronidazole and chloramphenicol. Meropenem and imipenem were the most active agents tested. On the basis of these results, meropenem appears to be a promising antimicrobial agent for anaerobic infections and warrants further clinical investigation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2553656     DOI: 10.1093/jac/24.suppl_a.113

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  7 in total

1.  Imipenem and meropenem: Comparison of in vitro activity, pharmacokinetics, clinical trials and adverse effects.

Authors:  G G Zhanel; A E Simor; L Vercaigne; L Mandell
Journal:  Can J Infect Dis       Date:  1998-07

2.  Meropenem versus imipenem/cilastatin in the treatment of intraabdominal infections requiring surgery.

Authors:  K Kanellakopoulou; H Giamarellou; P Papadothomakos; H Tsipras; J Chloroyiannis; R Theakou; P Sfikakis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-06       Impact factor: 3.267

3.  Susceptibilities of 394 Bacteroides fragilis, non-B. fragilis group Bacteroides species, and Fusobacterium species to newer antimicrobial agents.

Authors:  P C Appelbaum; S K Spangler; M R Jacobs
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

4.  Pharmacokinetics of meropenem compared to imipenem-cilastatin in young, healthy males.

Authors:  I Nilsson-Ehle; M Hutchison; S J Haworth; S R Norrby
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-02       Impact factor: 3.267

Review 5.  Meropenem. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy.

Authors:  L R Wiseman; A J Wagstaff; R N Brogden; H M Bryson
Journal:  Drugs       Date:  1995-07       Impact factor: 9.546

6.  Pharmacokinetics of meropenem in patients with intra-abdominal infections.

Authors:  A Bedikian; M P Okamoto; R K Nakahiro; J Farino; P N Heseltine; M D Appleman; A E Yellin; T V Berne; M A Gill
Journal:  Antimicrob Agents Chemother       Date:  1994-01       Impact factor: 5.191

7.  A ten years (2000-2009) surveillance of resistant Enterobacteriaceae in Zhejiang Province, China.

Authors:  Rong Zhang; Tomoaki Ichijo; Yan-Yan Hu; Hong-Wei Zhou; Nobuyasu Yamaguchi; Masao Nasu; Gong-Xiang Chen
Journal:  Microb Ecol Health Dis       Date:  2012-03-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.